OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101
OKYO Pharma 表示，OK-101 在其首個 OK-101 人體 2 期試驗中對包括眼痛緩解在內的乾眼病的多種體徵和症狀具有統計學意義